首页> 外文期刊>Cancer biology & therapy >A potential therapeutic strategy to combat leukemia virus infection.
【24h】

A potential therapeutic strategy to combat leukemia virus infection.

机译:对抗白血病病毒感染的潜在治疗策略。

获取原文
获取原文并翻译 | 示例
           

摘要

To test the concept that a replication-competent retrovirus carrying a suicide gene could have potential utility in the control of the natural virus infection in mammalian species, we constructed derivatives of a feline leukemia virus (FeLV) that is commonly associated with leukemia-lymphomas in this species. The FeLV, Rickard strain, subgroup A (FRA) genome contained at the 3' end of the envgene, an insert of an internal ribosomal entry site (IRES) linked to cDNA sequence of either herpes simplex virus thymidine kinase (HSV-TK) or a truncated HSV-TK (HSV-ATK) or yeast cytosine deaminase (CD). These constructs were transfected into feline fibroblast cells (H927). The viruses produced were determined to be replication-competent. The stable propagation of the full-length transgene was, however, dependent on the size of the insert, IRES-CD being the smallest in size (1031 bp) exhibiting maximal stability for at least up to six months. The protein products of the transgenes could be detected, despite the appearance of deleted proviruses at late passages. The transduced cells were susceptible to cytotoxic killing when the appropriate prodrug, ganciclovir (GCV), acyclovir (ACV) or 5-fluorocytosine (5-FC) was added to the culture medium. H927 cells, infected with another subgroup of FeLV, namely, FeLV-B or FeLV-C, could be superinfected by the FRA-suicide gene viruses and thus, subjected to killing. Interestingly, at an early stage of infection by the parental FRA, H927 cells could also be reinfected by the same subgroup FRA constructs to induce the suicide effect. Among the three constructs, the vector with the CD gene was determined to be superior to others in terms of stability, therapeutic index and bystander effect in the cell culture test system. While the in vivo correlates of the therapeutic effect in the feline model remain to be determined, our results do encourage investigation of the same concept in the control of HTLV and, perhaps even, HIV infection in humans.
机译:为了测试带有自杀基因的具有复制能力的逆转录病毒可能具有控制哺乳动物物种天然病毒感染的潜在效用,我们构建了猫白血病病毒(FeLV)的衍生物,该病毒通常与白血病淋巴瘤相关这个物种。 Felv Rickard菌株A亚组(FRA)基因组包含在envgene的3'末端,是一个内部核糖体进入位点(IRES)的插入片段,该位点与单纯疱疹病毒胸苷激酶(HSV-TK)或截短的HSV-TK(HSV-ATK)或酵母胞嘧啶脱氨酶(CD)。将这些构建体转染到猫成纤维细胞(H927)中。确定产生的病毒具有复制能力。但是,全长转基因的稳定繁殖取决于插入片段的大小,IRES-CD的大小最小(1031 bp),在至少六个月内表现出最大的稳定性。尽管在后期传代出现了缺失的前病毒,仍可以检测到转基因的蛋白质产物。当将适当的前药,更昔洛韦(GCV),阿昔洛韦(ACV)或5-氟胞嘧啶(5-FC)添加到培养基中时,转导的细胞容易受到细胞毒性的杀死。感染了FeLV另一个亚群(即FeLV-B或FeLV-C)的H927细胞可能会被FRA自杀基因病毒超感染,从而被杀死。有趣的是,在亲本FRA感染的早期,H927细胞也可以被相同的亚组FRA构建体再感染以诱导自杀作用。在这三种构建体中,具有CD基因的载体在细胞培养测试系统中的稳定性,治疗指数和旁观者效应方面被确定优于其他载体。虽然在猫科动物模型中体内治疗效果的相关性尚待确定,但我们的结果确实鼓励对控制HTLV甚至可能感染人类HIV的同一概念进行研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号